Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

 Saturday 15th June, SOE 2019 – Guidelines to the Practical Workup of Common Neuro-Ophthalmological

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 16th 2019

Coverage of the session ‘Guidelines to the Practical Workup of Common Neuro-Ophthalmological Findings’ at SOE 2019, featuring:

– Optic Disc Edema, Nicholas Volpe (0:10)
– Anisocoria, Jonathan Trob (16:10)
– Homonymous Hemianopia, Gordon Plant (32:58)
– Unexplained Visual Loss Karl Golni (50.12)

Filmed in partnership with the European Society of Ophthalmology (SOE) at the SOE 2019 meeting in Nice, France.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup